Allergan receives FDA approval for breast implants

11 Oct 2016

Global pharmaceutical company Allergan has received approval from the US Food and Drug Administration (FDA) to market the Natrelle Inspira Cohesive breast implants

The implant line is said to be part of a newer category of breast implants that contain high-strength silicone gel.

David Nicholson, chief research and development officer at Allergan, said, “Natrelle Inspira Cohesive breast implants are just the latest examples of our commitment to innovation in breast aesthetics and plastic surgery, and we are proud that we are able to continue to offer advancements in technology that allow physicians and their patients more options.”

Comments

Log-in to post a comment